DLTNF: AI 评分 42/100 — AI 分析 (4月 2026)

Delta 9 Cannabis Inc. is an integrated cannabis company operating in Canada, involved in cultivation, processing, distribution, and retail sales of medical and recreational cannabis products. The company owns and operates 35 retail stores under the Delta 9 brand across the Canadian Prairies.

Key Facts: AI Score: 42/100 Sector: Healthcare

公司概况

概要：

Delta 9 Cannabis Inc. is a Canadian integrated cannabis company involved in cultivation, processing, distribution, and retail. With 35 retail stores across the Canadian Prairies, Delta 9 offers a range of cannabis products, including dried flowers, oils, and derivative products, catering to both medical and recreational markets.

DLTNF是做什么的？

Delta 9 Cannabis Inc., incorporated in 2001 and headquartered in Winnipeg, Canada, operates as an integrated cannabis company. Through its subsidiary, Delta 9 Bio-Tech Inc., the company cultivates, processes, extracts, and distributes cannabis products. Delta 9's operations span the entire cannabis value chain, from cultivation to retail sales. The company's product portfolio includes dried cannabis flowers, pre-rolls, decontamination pods, dried sift cannabis, oils, and extracted and derivative products. Delta 9 also provides grow pods and live plants to other licensed and pre-licensed cannabis companies. In addition to its product offerings, Delta 9 operates a medical clinic providing physician consultation services for patients seeking medical cannabis prescriptions. As of April 20, 2022, Delta 9 owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies, solidifying its presence in the regional cannabis market. Delta 9 continues to expand its retail footprint and product offerings to meet the evolving demands of the cannabis market.

DLTNF的投资论点是什么？

Delta 9 Cannabis Inc. presents a speculative investment opportunity in the evolving Canadian cannabis market. The company's integrated business model, encompassing cultivation, processing, distribution, and retail, offers potential for revenue generation across the value chain. However, with a negative profit margin of -24.6% and a negative gross margin of -3.4%, the company's profitability is a concern. Future growth hinges on expanding retail operations, optimizing production costs, and capitalizing on emerging cannabis product trends. Investors should closely monitor the company's ability to achieve profitability and navigate the competitive landscape. The company's P/E ratio is -0.05.

DLTNF在哪个行业运营？

Delta 9 Cannabis Inc. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing competition, evolving regulations, and shifting consumer preferences. Delta 9 competes with other licensed producers and retailers, vying for market share in both the medical and recreational cannabis segments. The Canadian cannabis market is expected to continue growing, driven by increasing legalization and acceptance of cannabis products. Companies like Delta 9 must adapt to changing regulations and consumer demands to remain competitive.

Drug Manufacturers - Specialty & Generic

Healthcare

DLTNF有哪些增长机遇？

Expansion of Retail Footprint: Delta 9 can expand its retail presence beyond the Canadian Prairies to other provinces, increasing its market reach and revenue potential. The Canadian cannabis retail market is projected to reach several billion dollars in the coming years, offering significant growth opportunities for companies with established retail networks. The timeline for expansion depends on regulatory approvals and capital availability.
Product Innovation and Diversification: Delta 9 can invest in research and development to create new and innovative cannabis products, catering to evolving consumer preferences. This includes developing new formulations, delivery methods, and product formats. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly, presenting opportunities for Delta 9 to diversify its product portfolio. The timeline for product development and launch is typically 12-18 months.
Strategic Partnerships and Acquisitions: Delta 9 can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, or research institutions. Acquisitions can provide access to new markets, technologies, or product lines. The timeline for partnerships and acquisitions varies depending on the specific opportunities.
International Expansion: Delta 9 can explore opportunities to expand its operations internationally, particularly in countries with legal cannabis markets. This includes exporting cannabis products, establishing joint ventures, or acquiring foreign cannabis companies. The global cannabis market is growing rapidly, offering significant long-term growth potential. The timeline for international expansion depends on regulatory approvals and market conditions.
Medical Cannabis Focus: Delta 9 can focus on expanding its medical cannabis business, catering to patients seeking cannabis-based therapies. This includes developing new medical cannabis products, partnering with healthcare providers, and conducting clinical research. The medical cannabis market is growing steadily, driven by increasing awareness of the therapeutic benefits of cannabis. The timeline for medical cannabis initiatives depends on regulatory approvals and clinical trial results.

Delta 9 Cannabis Inc. operates as an integrated cannabis company, participating in cultivation, processing, distribution, and retail sales.
The company owns and operates 35 retail stores under the Delta 9 brand name across the Canadian Prairies as of April 20, 2022.
Delta 9's product portfolio includes dried cannabis flowers, pre-rolls, oils, and extracted products, catering to both medical and recreational markets.
The company has a negative profit margin of -24.6% and a negative gross margin of -3.4%, indicating profitability challenges.
Delta 9's beta of 1.13 suggests that the stock is more volatile than the market average.

DLTNF提供哪些产品和服务？

Cultivates cannabis plants in controlled environments.
Processes raw cannabis into various product forms.
Extracts cannabinoids to create oils and concentrates.
Wholesales cannabis products to other licensed retailers.
Operates retail stores under the Delta 9 brand.
Sells medical and recreational cannabis products.
Provides physician consultation services for medical cannabis prescriptions.

DLTNF如何赚钱？

Vertically integrated operations from cultivation to retail.
Revenue generation through wholesale and retail sales of cannabis products.
Medical clinic services providing cannabis prescriptions.
Sales of grow pods and live plants to other licensed producers.

Recreational cannabis consumers.
Medical cannabis patients with prescriptions.
Other licensed cannabis retailers (wholesale).
Licensed and pre-licensed cannabis companies (grow pods and live plants).

Integrated operations provide control over the entire value chain.
Established retail presence in the Canadian Prairies.
Proprietary grow pod technology.
Delta 9 brand recognition.

什么因素可能推动DLTNF股价上涨？

Ongoing: Expansion of retail operations to new locations.
Ongoing: Development and launch of new cannabis products.
Ongoing: Potential changes in cannabis regulations in Canada.
Upcoming: Announcement of strategic partnerships or acquisitions.
Upcoming: Positive financial results demonstrating improved profitability.

DLTNF的主要风险是什么？

Ongoing: Intense competition in the Canadian cannabis market.
Ongoing: Evolving regulations and compliance requirements.
Potential: Fluctuations in cannabis prices affecting revenue.
Potential: Economic downturn reducing consumer spending on cannabis.
Potential: Delays in regulatory approvals for new products or expansion plans.

DLTNF的核心优势是什么？

Integrated operations across the cannabis value chain.
Established retail presence in the Canadian Prairies.
Proprietary grow pod technology.
Delta 9 brand recognition.

DLTNF的劣势是什么？

Negative profit margin and gross margin.
Limited geographic presence compared to larger competitors.
Reliance on the Canadian cannabis market.
Small market capitalization.

DLTNF有哪些机遇？

Expansion of retail footprint to other provinces.
Product innovation and diversification.
Strategic partnerships and acquisitions.
International expansion.

DLTNF面临哪些威胁？

Increasing competition in the Canadian cannabis market.
Evolving regulations and compliance requirements.
Fluctuations in cannabis prices.
Economic downturn affecting consumer spending.

DLTNF的竞争对手是谁？

Acreage Holdings Inc. — Acreage Holdings has a wider geographic presence in the US cannabis market. — (ACNNF)
ATI Physical Therapy, Inc. — ATI Physical Therapy operates in a different segment of the healthcare sector. — (ATIP)
Columbia Care Inc. — Columbia Care has a broader range of cannabis products and services. — (CIMVF)
EnWave Corporation — EnWave focuses on dehydration technology, not cannabis production. — (EEVVF)
Global Cannabis Applications Corp. — Global Cannabis Applications Corp. focuses on technology solutions for the cannabis industry. — (GABLF)

Key Metrics

MoonshotScore: 42/100

Company Profile

CEO: John William Arbuthnot IV
Headquarters: Winnipeg, CA
Employees: 200
Founded: 2017

AI Insight

AI analysis pending for DLTNF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Delta 9 Cannabis Inc. do?

Delta 9 Cannabis Inc. is an integrated cannabis company operating in Canada. The company cultivates, processes, extracts, and distributes cannabis products through its subsidiary, Delta 9 Bio-Tech Inc. Delta 9's operations span the entire cannabis value chain, from cultivation to retail sales. The company's product portfolio includes dried cannabis flowers, pre-rolls, oils, and extracted products, catering to both medical and recreational markets. As of April 20, 2022, Delta 9 owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies.

What do analysts say about DLTNF stock?

AI analysis is pending for DLTNF. Generally, analyst opinions on cannabis stocks can vary widely depending on factors such as regulatory changes, market competition, and company-specific performance. Investors should consult multiple sources of information and conduct their own due diligence before making investment decisions. Key valuation metrics to consider include revenue growth, profitability, and market share.

What are the main risks for DLTNF?

The main risks for Delta 9 Cannabis Inc. include intense competition in the Canadian cannabis market, evolving regulations and compliance requirements, fluctuations in cannabis prices, and the potential for an economic downturn to reduce consumer spending on cannabis. The company's negative profit margin and gross margin also pose significant financial risks. Additionally, as an OTC-listed stock, DLTNF is subject to risks associated with limited financial disclosure, lower trading volumes, and potential price volatility.